Authors
Latest:
Dr Blanco on Unmet Needs for Pediatric Patients With Relapsed Brain TumorsJezabel Rodriguez-Blanco, PhD, discusses unmet needs for pediatric patients with relapsed brain tumors, including the need for additional treatment approaches for these patients.
Latest:
Dr. Simons on Racial Disparities Reported in Luminal Breast CancerYael Simons, MD, discusses the racial disparities seen in African Americans patients with luminal breast cancer.
Latest:
Dr Igor Astsaturov Appointed Inaugural Holder of Paul F. Engstrom Professorship in Oncology at Fox Chase Cancer CenterIgor Astsaturov, MD, PhD, has been appointed inaugural holder of the Paul F. Engstrom Professorship in Oncology.
Latest:
Kelsen on DEI Initiatives at Columbia University in Patients With CancerMoshe Kelsen, MBA, discusses ongoing initiatives that aim to improve diversity, equity, and inclusion for patients with cancer receiving treatment at Columbia University.
Latest:
Dr Pistilli on Understanding Dynamic HER2 Expression in Metastatic Breast CancerBarbara Pistilli, MD, discusses the importance of understanding how HER2 expression can change over time when assessing target expression in metastatic breast cancer.
Latest:
Dr. Ramaswamy on the Real-World Data Implications of Palbociclib in HR-Positive Breast CancerBhuvaneswari Ramaswamy, MD, discusses the importance of real-world data when considering the efficacy of the CDK 4/6 inhibitor palbociclib in hormone receptor–positive breast cancer.
Latest:
Dr. Tsai on Ongoing Research Efforts in Pancreatic CancerSusan Tsai, MD, MHS, discusses ongoing research efforts being made in the realm of pancreatic cancer.
Latest:
Survey Aims to Identify COVID-19–Related Health Care Challenges in Latin AmericaOutbreaks of coronavirus disease 2019 are on the rise in Latin America, with more than 4 million confirmed cases. In response to this health crisis, elective medical procedures, including cancer screening and care, as well as treatment for conditions beyond the virus, have been held.
Latest:
Dr Nastoupil on the Background of the TRANSCEND FL Trial in Follicular LymphomaLoretta J. Nastoupil, MD, discusses the rationale for launching the phase 2 TRANSCEND FL trial evaluating lisocabtagene maraleucel in patients with relapsed/refractory follicular lymphoma, highlighting the background for investigating this treatment approach.
Latest:
Dr Harpole on the Design of an Exploratory Analysis of the AEGEAN Trial in NSCLCDavid Harpole, MD, discusses on the rationale and design of an exploratory analysis of the phase 3 AEGEAN trial in patients with EGFR-mutated non–small cell lung cancer, which he presented at the 2023 IASLC World Conference on Lung Cancer.
Latest:
Second-Line Treatment of SCLCVamsidhar Velcheti, MD, leads the discussion on the current standard of care and approaching the treatment of second-line SCLC.
Latest:
Dr Jia on the Evolving Role of Metastasis-Directed Radiotherapy in Prostate CancerAngela Jia, MD, PhD, discusses the current standing of metastasis-directed radiotherapy in prostate cancer and identifies some lingering questions surrounding the modality.
Latest:
Dr Park on the Assessment of Robot-Assisted Nipple Sparing Mastectomy in Breast CancerKo Un “Clara” Park, MD discusses the assessment of robot-assisted nipple sparing mastectomy in breast cancer.
Latest:
Renal Cell Carcinoma: Future Evolutions in CareShared insight on the evolving state of renal cell carcinoma management and hope for future growth in the treatment landscape.
Latest:
EGFR+ NSCLC: Advice for Community OncologistsA panel of experts in thoracic oncology concludes the discussion by emphasizing the importance of conducting reflex molecular testing, considering systemic therapy in all patients, and utilizing shared decision-making models.
Latest:
Dr Shields on Updates in Upfront Systemic Therapy in ES-SCLCMisty D. Shields, MD, PhD, discusses systemic therapy updates for patients with extensive-stage small cell lung cancer.
Latest:
Scientists Create Nanoparticle That Helps Fight Solid TumorsResearchers from Wake Forest University School of Medicine have discovered a possible new approach in treating solid tumors through the creation of a novel nanoparticle.
Latest:
Dr. Maziéres on the Evaluation of Tepotinib Plus Osimertinib in EGFR-mutated NSCLCJulien Maziéres, MD, PhD, discusses the evaluation of tepotinib plus osimertinib in EGFR-mutated non–small cell lung cancer.
Latest:
Dr Mohan on CAR T-cell Therapies and Bispecific Antibodies in R/R Multiple MyelomaMeera Mohan, MD, MS, FACP, discusses the significance of CAR T-cell therapies and bispecific antibodies in patients with relapsed/refractory multiple myeloma.
Latest:
Dr. Garutti on the Potential Shift to Neoadjuvant Therapy in MelanomaMattia Garutti, MD, discusses the potential shift to neoadjuvant therapy in melanoma.
Latest:
Review of the SELECT-AML-1 Trial and the Future of Newly Diagnosed AMLDaniel Pollyea, MD, MS, reviews the ongoing SELECT-AML-1 trial and comments on novel therapies and biomarkers in patients with newly diagnosed unfit AML.
Latest:
Dr. Azad on the Significance of the PROfound Trial in mCRPCArun Azad, PhD, discusses the significance of the PROfound trial in metastatic castration-resistant prostate cancer.
Latest:
Dr. Farrington on the Importance of Genetic Testing in CRCCaroline Farrington, PhD, discusses the importance of genetic testing in colorectal cancer.
Latest:
Basal Cell Carcinoma Clinical PearlsDrs Babakoohi and Atlas share clinical pearls for community oncologists on treating basal cell carcinoma.
Latest:
Dr Gruenwald on Tumor Responses With Lenvatinib Plus Pembrolizumab in Advanced RCCViktor Gruenwald, MD, PhD, discusses key results from a post-hoc analysis of the phase 3 CLEAR trial in advanced renal cell carcinoma.
Latest:
Dr Lin on the Effect of Perioperative Treatment on Surgical Approaches in NSCLCJules Lin, MD, discusses how approaches to surgical intervention in non–small cell lung cancer may have shifted with the increasing use of targeted therapy and immunotherapies in the adjuvant and neoadjuvant setting.
Latest:
Dr. Wang on the Rationale for Viral Hepatitis Screening to Prevent HCCSu H. Wang, MD, MPH, discusses the rationale for the integration of viral hepatitis screening and care in a hospital system as the first steps for preventing liver cancers like hepatocellular carcinoma.
Latest:
Dr Jones on the Application of ctDNA Testing in CRCJeremy C. Jones, MD, discusses the applications of circulating tumor DNA testing in colorectal cancer.
